HuMax-CD4

· Genmab

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for HuMax-CD4, covering 2023-04-28 to 2024-03-18. Get the full timeline:

Most recent: Clinical Trial Update: HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma [Phase 2, Phase 3]